600 filings
ARS
2023 FY
DNLI
Denali Therapeutics Inc
18 Apr 24
Annual report to shareholders
4:05pm
DEFA14A
DNLI
Denali Therapeutics Inc
18 Apr 24
Additional proxy soliciting materials
4:04pm
DEF 14A
DNLI
Denali Therapeutics Inc
Definitive proxy
18 Apr 24
4:03pm
4
DNLI
Denali Therapeutics Inc
17 Apr 24
Denali Therapeutics / VICKI L SATO ownership change
5:14pm
144
DNLI
Denali Therapeutics Inc
15 Apr 24
Notice of proposed sale of securities
4:32pm
4
rn186e4xu9z6yt wz
2 Apr 24
Denali Therapeutics / Steve E. Krognes ownership change
6:07pm
144
r2ayb37 bcgz
1 Apr 24
Notice of proposed sale of securities
4:35pm
4
hy1ugnnkxqb udd
29 Mar 24
Denali Therapeutics / Ryan J. Watts ownership change
5:59pm
S-3ASR
ke3eswc4jl6g675an
22 Mar 24
Automatic shelf registration
4:01pm
4
8ldbdjra oe
19 Mar 24
Denali Therapeutics / VICKI L SATO ownership change
4:27pm
D
ks8v1ern du
1 Mar 24
$499.73 mm in equity / options, sold $499.73 mm, 11 investors
4:51pm
S-8
9amijq4
27 Feb 24
Registration of securities for employees
8:21pm
8-K
h2a0hdrslyqg0o3gabv
27 Feb 24
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
8:07am
8-K
9zoh4
27 Feb 24
Denali Therapeutics Announces $500 million Private Placement Equity Financing
8:03am
4
qfgpj9ftnmb648vwop
20 Feb 24
Denali Therapeutics / VICKI L SATO ownership change
5:38pm
8-K
al9 0c06mx3icnigpoy
16 Feb 24
Regulation FD Disclosure
8:02am
4
kuhv 9d3c
15 Feb 24
Denali Therapeutics / Steve E. Krognes ownership change
9:16pm
4
pxkgni xhem5q
15 Feb 24
Denali Therapeutics / Ryan J. Watts ownership change
9:15pm
4
dz3q86g u9x
15 Feb 24
Denali Therapeutics / Carole Ho ownership change
9:14pm